ZP5-9676

Our first drug candidate, ZP5-9676, is a single-dose therapy intended to treat the major Soil-Transmitted Helminths, including Ascaris (roundworm), Trichuris (whipworm), Necator americanus and the uncommon Ancylostoma duodenale (hookworm). Given the disproportionate impact on children, ZP5-9676 is designed to be a single-dose therapy in an easy to administer, child-friendly formulation.   ZP5-9676 is also intended to remain at the site of infection (intestine) rather than being widely distributed throughout the bloodstream, minimizing systemic drug exposure and thereby rendering it safe for use in all patients including children.